STOCK TITAN

The Oncology Institute to Participate at the Jefferies Value-Based Healthcare Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

CERRITOS, Calif., March 8, 2022 – The Oncology Institute of Hope and Innovation (NASDAQ: TOI) announced that CEO Brad Hively will participate in the Jefferies Value-Based Healthcare Summit in Miami on March 14 at 1:40 pm EST. Hively has over 20 years of healthcare experience, transforming TOI into a leading oncology provider with over 50 clinics nationwide. The institute offers innovative, value-based cancer care to approximately 1.6 million patients. Investors can access a webcast of the event on the company’s website.

Positive
  • None.
Negative
  • None.

CERRITOS, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, will participate at the Jefferies Value-Based Healthcare Summit in Miami, Florida, on Monday, March 14. Hively will host a fireside chat at the conference at 1:40 pm EST.

With over 20 years of executive leadership experience in healthcare, Hively has scaled TOI from a regional oncology group to a nationally recognized leader in oncology care by spearheading the company’s public listing in November of 2021. A firm believer in driving healthcare’s value-based care transformation by example, TOI boasts more than 50 clinic locations across the country to offer innovative cancer care that improves patient lives and delivers comprehensive treatment at affordable cost.

Interested investors and other parties may listen to a simultaneous webcast of the presentations by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/. The online replay will be available for a limited time shortly following the call.

About The Oncology Institute

Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.6 million patients including clinical trials, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced healthcare organizations. With 80+ employed clinicians and more than 600 teammates in more than 50 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com 

Contacts

Media

The Oncology Institute
Julie Korinke
juliekorinke@theoncologyinstitute.com 
(562) 735-3226 x 88806

Revive
Michael Petrone
mpetrone@reviveagency.com 
(615) 760-4542

Investors

Solebury Trout
Maria Lycouris
investors@theoncologyinstitute.com


FAQ

What date is the Jefferies Value-Based Healthcare Summit featuring TOI's CEO?

The Jefferies Value-Based Healthcare Summit is on March 14, 2022.

What time will Brad Hively speak at the Jefferies Summit?

Brad Hively will host a fireside chat at 1:40 pm EST.

How can investors listen to the TOI presentation at the Jefferies Summit?

Investors can listen to a webcast of the presentation on The Oncology Institute's Investor Relations website.

What is the stock symbol for The Oncology Institute?

The stock symbol for The Oncology Institute is TOI.

How many clinic locations does The Oncology Institute have?

The Oncology Institute has more than 50 clinic locations across the United States.

The Oncology Institute, Inc.

NASDAQ:TOI

TOI Rankings

TOI Latest News

TOI Stock Data

9.96M
60.54M
19.56%
47.59%
0.33%
Medical Care Facilities
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
CERRITOS